111 related articles for article (PubMed ID: 36232820)
1. Tumor-Informed Approach Improved ctDNA Detection Rate in Resected Pancreatic Cancer.
Watanabe K; Nakamura T; Kimura Y; Motoya M; Kojima S; Kuraya T; Murakami T; Kaneko T; Shinohara Y; Kitayama Y; Fukuda K; Hatanaka KC; Mitsuhashi T; Pittella-Silva F; Yamaguchi T; Hirano S; Nakamura Y; Low SK
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232820
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA.
Zvereva M; Roberti G; Durand G; Voegele C; Nguyen MD; Delhomme TM; Chopard P; Fabianova E; Adamcakova Z; Holcatova I; Foretova L; Janout V; Brennan P; Foll M; Byrnes GB; McKay JD; Scelo G; Le Calvez-Kelm F
EBioMedicine; 2020 May; 55():102462. PubMed ID: 32249202
[TBL] [Abstract][Full Text] [Related]
3. Circulating Tumor DNA (ctDNA) and Its Role in Gynecologic Malignancies.
Pomerantz T; Brooks R
Curr Treat Options Oncol; 2024 Apr; 25(4):510-522. PubMed ID: 38472567
[TBL] [Abstract][Full Text] [Related]
4. Comparison of tumor-informed and tumor-naïve sequencing assays for ctDNA detection in breast cancer.
Santonja A; Cooper WN; Eldridge MD; Edwards PAW; Morris JA; Edwards AR; Zhao H; Heider K; Couturier DL; Vijayaraghavan A; Mennea P; Ditter EJ; Smith CG; Boursnell C; Manzano García R; Rueda OM; Beddowes E; Biggs H; Sammut SJ; Rosenfeld N; Caldas C; Abraham JE; Gale D
EMBO Mol Med; 2023 Jun; 15(6):e16505. PubMed ID: 37161793
[TBL] [Abstract][Full Text] [Related]
5. From Somatic Variants Toward Precision Oncology: An Investigation of Reporting Practice for Next-Generation Sequencing-Based Circulating Tumor DNA Analysis.
Peng R; Zhang R; Horan MP; Zhou L; Chai SY; Pillay N; Tay KH; Badrick T; Li J
Oncologist; 2020 Mar; 25(3):218-228. PubMed ID: 32162803
[TBL] [Abstract][Full Text] [Related]
6. Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas.
Mutter JA; Alig SK; Esfahani MS; Lauer EM; Mitschke J; Kurtz DM; Kühn J; Bleul S; Olsen M; Liu CL; Jin MC; Macaulay CW; Neidert N; Volk T; Eisenblaetter M; Rauer S; Heiland DH; Finke J; Duyster J; Wehrle J; Prinz M; Illerhaus G; Reinacher PC; Schorb E; Diehn M; Alizadeh AA; Scherer F
J Clin Oncol; 2023 Mar; 41(9):1684-1694. PubMed ID: 36542815
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biological determinants of circulating tumor DNA detection and prognostication using a next-generation sequencing panel assay.
Hsiehchen D; Espinoza M; Gerber DE; Beg MS
Cancer Biol Ther; 2021 Sep; 22(7-9):455-464. PubMed ID: 34392779
[TBL] [Abstract][Full Text] [Related]
8. Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies.
Recio F; Scalise CB; Loar P; Lumish M; Berman T; Peddada A; Kalashnikova E; Rivero-Hinojosa S; Beisch T; Nicosia B; Farmer T; Dutta P; Malhotra M; ElNaggar AC; Liu MC; Vaccarello L; Holloway RW
Gynecol Oncol; 2024 Mar; 182():63-69. PubMed ID: 38262240
[TBL] [Abstract][Full Text] [Related]
9. Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA.
Kurtz DM; Soo J; Co Ting Keh L; Alig S; Chabon JJ; Sworder BJ; Schultz A; Jin MC; Scherer F; Garofalo A; Macaulay CW; Hamilton EG; Chen B; Olsen M; Schroers-Martin JG; Craig AFM; Moding EJ; Esfahani MS; Liu CL; Dührsen U; Hüttmann A; Casasnovas RO; Westin JR; Roschewski M; Wilson WH; Gaidano G; Rossi D; Diehn M; Alizadeh AA
Nat Biotechnol; 2021 Dec; 39(12):1537-1547. PubMed ID: 34294911
[TBL] [Abstract][Full Text] [Related]
10. Circulating Tumor DNA Profiling Approach Based on In Silico Background Elimination Guides Chemotherapy in Nasopharyngeal Carcinoma.
Li M; Xie S; Hou T; Shao T; Kuang J; Liu C; Qu Y; Lu C; Liu J; Liu X; Zhu L; Zhu L
Clin Pharmacol Ther; 2024 May; 115(5):993-1006. PubMed ID: 38037868
[TBL] [Abstract][Full Text] [Related]
11. Prospective Evaluation of Circulating Tumor DNA using Next Generation Sequencing as a Biomarker during Neoadjuvant Chemotherapy in Localized Pancreatic Cancer.
Shah D; Wells A; Cox M; Dawravoo K; Abad J; D'Souza A; Suh G; Bayer R; Chaudhry S; Zhang Q; Cristofanilli M; Bentrem D; Chawla A
Ann Surg; 2024 Jan; ():. PubMed ID: 38258582
[TBL] [Abstract][Full Text] [Related]
12.
Arimura A; Sakai K; Kaneshiro K; Morisaki T; Hayashi S; Mizoguchi K; Yamada M; Kai M; Ono M; Nishio K; Nakamura M; Kubo M
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539518
[TBL] [Abstract][Full Text] [Related]
13. Bead-Based Isolation of Circulating Tumor DNA from Pancreatic Cancer Patients Enables High Fidelity Next Generation Sequencing.
Balendran-Braun S; Kieler M; Liebmann-Reindl S; Unseld M; Bianconi D; W Prager G; Streubel B
Cancer Manag Res; 2021; 13():6249-6261. PubMed ID: 34393517
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor DNA analysis guiding adjuvant treatment in resected stage III cholangiocarcinoma: a case report.
Yu J; Avriett TA; Ray CM; Kim RD
J Gastrointest Oncol; 2024 Feb; 15(1):485-490. PubMed ID: 38482231
[TBL] [Abstract][Full Text] [Related]
15. Beyond basics: Key mutation selection features for successful tumor-informed ctDNA detection.
Nesic M; Rasmussen MH; Henriksen TV; Demuth C; Frydendahl A; Nordentoft I; Dyrskjøt L; Andersen CL
Int J Cancer; 2024 Apr; ():. PubMed ID: 38623608
[TBL] [Abstract][Full Text] [Related]
16. A Practical Approach to Interpreting Circulating Tumor DNA in the Management of Gastrointestinal Cancers.
Allan Z; Liu DS; Lee MM; Tie J; Clemons NJ
Clin Chem; 2024 Jan; 70(1):49-59. PubMed ID: 38175583
[TBL] [Abstract][Full Text] [Related]
17. Plasma ctDNA enables early detection of temozolomide resistance mutations in glioma.
Jones JJ; Jones KL; Wong SQ; Whittle J; Goode D; Nguyen H; Iaria J; Stylli S; Towner J; Pieters T; Gaillard F; Kaye AH; Drummond KJ; Morokoff AP
Neurooncol Adv; 2024; 6(1):vdae041. PubMed ID: 38596716
[TBL] [Abstract][Full Text] [Related]
18. Mutation detection using plasma circulating tumor DNA (ctDNA) in a cohort of asymptomatic adults at increased risk for cancer.
Kammesheidt A; Tonozzi TR; Lim SW; Braunstein GD
Int J Mol Epidemiol Genet; 2018; 9(1):1-12. PubMed ID: 29531639
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor DNA detection in head and neck cancer: evaluation of two different detection approaches.
Perdomo S; Avogbe PH; Foll M; Abedi-Ardekani B; Facciolla VL; Anantharaman D; Chopard P; Calvez-Kelm FL; Vilensky M; Polesel J; Holcatova I; Simonato L; Canova C; Lagiou P; McKay JD; Brennan P
Oncotarget; 2017 Sep; 8(42):72621-72632. PubMed ID: 29069814
[TBL] [Abstract][Full Text] [Related]
20. ACEK Biosensor for the Minute-Scale Quantification of Breast Cancer ctDNA.
Wang K; Lin X; Zhang M; Yang M; Shi X; Xie M; Luo Y
Sensors (Basel); 2024 Jan; 24(2):. PubMed ID: 38257640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
